NCT00774969

Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease

Phase 1 Study to Evaluate the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri-Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: S.L.A. Pharma AG · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the blood levels of Metronidazole after application to the peri anal area after a single dose and 6 or 7 days application.

Conditions

• Perianal Crohns'

Interventions

Type	Name	Description
DRUG	Metronidazole	Metronidazole 10% ointment three times a day 7 days

Timeline

• Start date: 2007-10-01
• Primary completion: 2008-04-01
• Completion: 2008-04-01
• First posted: 2008-10-17
• Last updated: 2008-10-17

Locations

1 site across 1 country: United Kingdom